FDA Panel Backs Orexigen’s Diet Pill
by Melly Alazraki on Dec.07, 2010, under Towing
After the U.S. Food and Drug Administration rejected two other weight-loss pills earlier this year, an advisory panel has recommended the approval of Orexigen Therapeutics’s Contrave. If the FDA follows the recommendation, Contrave could become the first diet drug to win approval in a decade.
Continue reading FDA Panel Backs Orexigen’s Diet Pill
FDA Panel Backs Orexigen’s Diet Pill originally appeared on DailyFinance on Tue, 07 Dec 2010 20:30:00.
Filed Under: Company News, Health Care, Stocks in the News
-
You Can Reach Us At:
For All Of Your Towing and Recovery Needs.
Tele: (847) 587-6076
Fax: (847) 587-8610 Some Of Our Pics
1 Trackback or Pingback for this entry
May 10th, 2010 on 8:01 am
[...] rest is here: Internet-Focused Funds Ride the Next Growth Trend | Fox Lake … Bookmark [...]